A detailed history of Coppell Advisory Solutions LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 297 shares of LEGN stock, worth $9,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297
Previous 297 -0.0%
Holding current value
$9,735
Previous $18.3 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $17,003 - $20,712
297 New
297 $18.3 Million
Q2 2023

Aug 17, 2023

BUY
$46.28 - $75.01 $27,120 - $43,955
586 New
586 $41.1 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.